Unverified50% confidenceEventExact time
The drug regulatory authority released the world's first AI brain-computer interface medical device standard, planned for implementation starting September 1, 2027.
1
Sources
50%
Confidence
Long-term
Relevance
9/18/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedThe U.S. FDA has established a regulatory framework for AI/ML-based medical device software, and as of 2024 has approved or cleared more than 900 AI-driven medical devices.75% similarUnverified美国FDA在2021年发布《人工智能/机器学习医疗器械软件行动计划》，要求通过510(k)或PMA流程；欧盟MDR（2017/745法规）于2021年正式生效；中国NMPA于2021年发布《人工智能医疗器械注册审查指导原则》70% similarUnverifiedInsilico Medicine于2023年将其AI设计的候选药物推进至临床II期试验，成为首个完全由AI设计并进入临床阶段的药物分子70% similarVerifiedThe Interim Measures for the Management of Generative Artificial Intelligence Services officially came into effect on August 15, 2023, jointly issued by the Cyberspace Administration of China and six other departments, making it the world's first administrative regulation specifically targeting generative AI.69% similarUnverified2024年多家制药公司已将AI生成的候选分子推入针对神经退行性疾病的临床试验阶段69% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/930942API
curl https://kongchang.com/api/v1/knowledge/claims/930942MCP
get_claim(id=930942)